Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Danish biotech establishes online scientific collaboration network

Novozymes hopes to help tackle major health problems through HelloScience

Digital pharmaNovozymes has set up an online network for individuals and companies to collaborate on solutions to major scientific problems.

The Danish biotechnology company’s HelloScience network takes aim at five initial challenges, all based on a water theme they include developing an E. coli detection device.

Nearly 18,000 children die each day from diarrhea and other water-related diseases, mainly contracted from contaminated water or food. But current detection tests for E. coli bacteria take up to 24 hours to return a result.

Claus Crone Fuglsang, Novozymes’ head of research and technology, said: “Water and sanitation are at the heart of sustainable development. One out of every seven people does not have adequate access to safe water, and nearly one in four does not have adequate sanitation.

“Novozymes already provides a range of microbial solutions for treatment of both industrial and municipal wastewater, but we believe biotech in combination with other technologies can play an even bigger role. HelloScience provides a timely opportunity to bring new innovative solutions into the world of water and wastewater treatment.”

29th November 2017

From: Research

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
The rise of digital healthcare – fuelled by open innovation in healthtech hubs
How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...